Clinical Trial

Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for OA

Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
This trial will study the safety and efficacy of cultured allogeneic adult umbilical cord derived mesenchymal stem cells delivered intravenously and intraarticularly for the treatment of Osteoarthritis.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2021-11-29; most recent amendment 2025-06-05.
Status change: Active, Not Recruiting → Recruiting 2025-06-05
Status change: Recruiting → Active, Not Recruiting 2025-04-04
Trial Details
NCT Number NCT05147675
Lead Sponsor The Foundation for Orthopaedics and Regenerative Medicine
Conditions Osteoarthritis, Spinal Arthritis
Enrollment 92 participants
Start Date 2022-12-01
Primary Completion 2027-12-01 (estimated)
Study Completion 2027-12-01 (estimated)
Updated on ClinicalTrials.gov 2025-06-10